UCB’s Rystiggo Approved in China for Generalized Myasthenia Gravis
Belgium-based biopharma UCB (EBR: UCB) announced that it has received marketing approval from China‘’s National...
Belgium-based biopharma UCB (EBR: UCB) announced that it has received marketing approval from China‘’s National...
Renji Hospital, a comprehensive Class 3A hospital established in 1844 in Shanghai, has partnered with...
Partners AstraZeneca (NASDAQ: AZN) and Daiichi Sankyo (TYO: 4568) announced the first patient dosing in...
The National Medical Products Administration (NMPA) has released the “Measures for Optimizing Full Lifecycle Supervision...
US medical device and life sciences giant GE Healthcare Technologies Inc., (NASDAQ: GEHC) announced that...
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (SHA: 600276) announced that it has received additional indication approval...
Chinese companies Nanjing F&S Pharmatech Co., Ltd and Hunan Huize Biopharmaceutical Technology Co., Ltd, a...
China-based Huapont Life Sciences Co., Ltd (SHE: 002004) announced that it has received marketing approval...
China-based Annoroad Gene Technology (Beijing) Co., Ltd. has submitted an initial public offering (IPO) filing...
China-based Ascletis Pharma Inc. (HKG: 1672) announced positive interim results from a Phase Ib study...
Shanghai-based biotech Abbisko Therapeutics Co., Ltd (HKG: 2256) announced that its German partner Merck KGaA...